Rosendaal, F. R. Et Al. 2017. Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis. BLOOD , vol.130, no.15 , 1757-1759.

Rosendaal, F. R., Palla, R., Garagiola, I., Mannucci, P. M., & Peyvandi, F., (2017). Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis. BLOOD , vol.130, no.15, 1757-1759.

Rosendaal, Frits Et Al. "Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis," BLOOD , vol.130, no.15, 1757-1759, 2017

Rosendaal, Frits R. Et Al. "Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis." BLOOD , vol.130, no.15, pp.1757-1759, 2017

Rosendaal, F. R. Et Al. (2017) . "Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis." BLOOD , vol.130, no.15, pp.1757-1759.

@article{article, author={Frits R. Rosendaal Et Al. }, title={Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis}, journal={BLOOD}, year=2017, pages={1757-1759} }